NEW YORK and GUANGZHOU, China, Aug. 7, 2012 /PRNewswire/ -- Tanke BioSciences Corporation (OTCQB: TNBI) today said it has introduced a diverse array of water-soluble organic feed additives for the farm animal market. These additives -- comprising multi-vitamins joined with organic trace minerals -- are known to play a primary role in fostering optimal animal growth and health, said Tanke, and are generally considered easier to administer, more speedily digested, and more effective than their dry feed additive counterparts.
Currently, Tanke's new sales division markets one water-soluble organic feed additive product to the larger animal farms in seven of China's 22 provinces. By the end of this year the company expects to have completed development of four additional water-soluble organic products, three of which will be marketed by the new sales division to animal farms throughout China. The remaining product will be marketed by Tanke's original sales force to major seafood farms across the nation.
Revenue from these products is expected to increase quarter by quarter, said CEO and chairman Mr. Guixiong Qiu, and represent five to ten percent of total revenue in 2013 and 2014.
Additional revenue, however, may materialize from other new organic trace mineral products, said Mr. Qiu, including a line of proprietary feed additives aimed at strengthening farm animals' resistance against cancer and other major diseases. These products are formulated on the mineral selenium, which has thus far demonstrated impressive results in boosting animals' immune systems.
Tanke is currently China's largest producer of organic trace mineral additives, with some seven percent of the market.
About Tanke BioSciences Corporation
Founded in 1997, Tanke BioSciences Corp. (http://tanke-bio.com/) is a leading China-based agritech company developing, manufacturing and marketing animal feed additives and livestock nutritional products that address China's soaring demand for safe, reasonably priced food. All Tanke products are free of genetically modified organisms (GMOs), antibiotics, and are environment-friendly, making them optimal for animal consumption. The company's operations are based in Guangzhou, China, and its chief financial officer is located in New York City. For investor information, please go to http://ir.stockpr.com/tankebio/overview.
This press release and the statements of representatives of our officers, directors, employees and representatives related thereto contain or may contain forward-looking statements which are based upon the current beliefs and expectations of our management. Such statements contained in this release are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "guidance," "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "ultimately" and words of similar import, are intended to identify any forward-looking statements. The information contained in the forward looking statements is inherently uncertain, and our actual results may differ materially due to a number of factors, many of which are beyond our ability to predict or control, including, among others: (i) changes in the level of consumer spending or preferences or demand for our products; (ii) pressures from competition; (iii) our ability to hire and retain key personnel and our relationship with our employees; (iv) the performance of our distributors and other key vendors; (v) effectively carrying out and managing our growth strategies; (vi) failure to maintain the value and image of our brand and protect our intellectual property rights; (vii) seasonality; (viii) costs of materials and labor; (ix) sales, manufacturing, supply or distribution difficulties or disruptions; (x) compliance with or changes in Chinese, U.S. or international laws and regulations; (xi) costs as a result of operating as a public company; (xii) material weaknesses in internal controls; (xiii) interest rate and foreign currency risks; (xiv) our ability to maintain our land use and drug manufacturing rights in China; (xv) general economic and industry conditions in China and internationally, and other risks as more fully detailed in our filings with the Securities and Exchange Commission ("SEC"). Our filings with the SEC are available at www.sec.gov. You are urged to consider these factors carefully in evaluating our forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements which are qualified in their entirety by this cautionary statement. The forward-looking statements speak only as of the date on which they are made, and the company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances unless as required by applicable laws or regulations.
Tanke BioSciences Corp.
SOURCE Tanke BioSciences Corporation